← Back to Clinical Trials
Recruiting Phase 1 NCT05962424
HNC: Human Neural Circuits Electrophysiology During Cognition
Trial Parameters
Condition Psychiatric Disorder
Sponsor Stanford University
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-10-05
Completion 2030-09-01
Interventions
Ketamine Hydrochloride
Brief Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Eligibility Criteria
Inclusion Criteria: * Patient in clinical neuro inpatient units at Stanford Medical Center * Age \>18 years old * Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex) Exclusion Criteria: * Lifetime psychotic disorder * Pregnant or nursing females * Prior adverse ketamine response * Use of ketamine in past 7 days
Related Trials
NCT05577598
Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Co
View Trial →
NCT06227468
A Clinical Study to Map the HLA Genomic Region in the Greek Population
View Trial →
NCT06433583
Pilot Study on the Acceptability of Auricular Vagus Nerve Neurostimulation in Adolescents
View Trial →